Kevin McCaffrey

Most Recent Articles by Kevin McCaffrey

The FDA approves Amgen's biosimilar version of Humira

The FDA approves Amgen's biosimilar version of Humira

Amgen's drug is set to compete with AbbVie's Humira, which is the second-best selling drug in the U.S. in 2015.

Five things for pharma marketers to know: Thursday, September 22, 2016

Five things for pharma marketers to know: Thursday, September 22, 2016

Mylan CEO comes under fire at House Committee hearing; Abbott OxyContin reps went to great lengths to sell the pain pill; UnitedHealth drops Lantus

Campaign seeks to educate doctors about when to prescribe opioids

Campaign seeks to educate doctors about when to prescribe opioids

Some physicians say they believe they have a responsibility to address the opioid epidemic, but misinformation may hinder them in that pursuit.

Five things for pharma marketers to know: Tuesday, September 20, 2016

Five things for pharma marketers to know: Tuesday, September 20, 2016

GSK names new CEO; the FDA approves first Duchenne muscular dystrophy drug; Sanofi files Lantus patent lawsuit against Merck

Alexion uses superheroes, social media to raise rare-disease awareness

Alexion uses superheroes, social media to raise rare-disease awareness

Alexion launched a new superhero-themed awareness campaign to draw attention to four rare diseases that its products treat.

More Articles by Kevin McCaffrey

OPINION

Email Newsletters